Cover Image
Market Research Report

North America Liposome Drug Delivery Market Forecast to 2027- COVID 19 Impact and Analysis- by Product type; Technology; Application; and Country

Published by The Insight Partners Product code 967112
Published Content info 138 Pages
Delivery time: 1-2 business days
Price
Back to Top
North America Liposome Drug Delivery Market Forecast to 2027- COVID 19 Impact and Analysis- by Product type; Technology; Application; and Country
Published: September 16, 2020 Content info: 138 Pages
Description

Title:
North America Liposome Drug Delivery Market Forecast to 2027- COVID 19 Impact and Analysis- by Product type( Liposomal Doxurubicin, Liposomal Paclitxel, Liposomal Amphotericin B, Others); Technology( Stealth Liposome Technology, Non PEGylated Liposome Technology, Depofoam Liposome technology, Lysolipid thermally Sensitive Liposome Technology); Application( Fungal Diseases, Cancer Therapy, Pain management, Viral Vaccine); and Country.

The North America liposome drug delivery market is expected to reach US$ 2735.64 million by 2027 from US$ 1390.53 million in 2019. The market is estimated to grow with a CAGR of 9% from 2020 to 2027.

The liposome drug delivery market is growing primarily due to the Increasing Prevalence of chronic diseases, increasing demand for non-invasive drug delivery system along with rising R&D expenditures by pharmaceutical companies are some of the driving force of the market. Whereas, high cost associated with development of Non-invasive drug delivery system is about to hinder the market growth during forecast period.

The Liposome are novel drug delivery system (NDDS) , they are vesicular structures consisting of bilayers which form spontaneously when phospholipids are disappeared in water. They are microscopic vesicles in which an aqueous volume is entirely enclosed by a membrane composed of lipid bilayers.

Over the past few decades, research and development (R&D) in liposomal drug delivery systems is increasing across the world due to increasing prevalence of chronic disease. Drug delivery is the process of administering a pharmaceutical compound to achieve a therapeutic effect in humans. Liposomal drug delivery offers various advantages such as improved pharmacokinetics and pharmacodynamics, enhanced therapeutic efficacy, and decreased toxicity making these delivery systems ideal for patients suffering from various chronic conditions. According to the Centers for Disease Control and Prevention (CDC) in the 2019, almost 6 in 10 people in the US suffer from at least one chronic disease and 4 in 10 people have two or more chronic diseases.

Liposomes are rapidly gaining acceptance as nano-carriers for various pharmaceutical applications. Compositions of cholesterol and phospholipids are becoming increasingly useful in liposome drug delivery. As the nanoscience is optimizing liposome drug delivery, the pharmaceutical and biotechnology companies are exploring alternative compositions with cholesterol as well as new techniques such as nanotechnology to improve the stability and drug release profiles with the help of encapsulation and other techniques. They are using liposomes for the generation of extracellular vesicles by targeted cells.

Manufacturers in the liposome drug delivery market are ramping up their R&D activities in order to unlock new lipid compositions and strategies that help to optimize the drug transport and stability of liposomes.

Research institutes, pharmaceutical, and biotech companies are now focusing in collaborative work to address the COVID-19 outbreak. This has eventually shifted their focus from their regular supply of liposome drug delivery. Majority of the companies which are operating in the manufacturing segment of liposome drug delivery products are currently working on various therapeutic segment to tackle the pandemic situation. In the upcoming years, the research activities are expected to accelerate owing to their potential in treating wide range of diseases. The COVID-19 outbreak highlights potential vulnerabilities in both our drug supply chain and clinical infrastructure, including the availability of adequate clinician resources.

Some of the significant secondary sources for automated compounding systems market included in the report are the Food and Drug Administration (FDA), World Health Organization (WHO).

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America Liposome Drug Delivery market.Highlights key business priorities in order to assist companies to realign their business strategies.The key findings and recommendations highlight crucial progressive industry trends in the North America Liposome drug delivery market, thereby allowing players across the value chain to develop effective long-term strategies.Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table of Contents
Product Code: TIPRE00014203

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 North America Liposome Drug Delivery Market - By Product
    • 1.3.2 North America Liposome Drug Delivery Market - By Technology
    • 1.3.3 North America Liposome Drug Delivery Market - By Application
    • 1.3.4 North America Liposome Drug Delivery Market - By Geography

2. North America Liposome Drug Delivery Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Liposome Drug Delivery Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Liposome Drug Delivery Market - North America PEST Analysis
  • 4.3 Expert Opinion

5. North America Liposome Drug Delivery Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising prevalence of Chronic Diseases
    • 5.1.2 Growing Demand for Non-Invasive Drug Delivery Devices
    • 5.1.3 Increasing R&D Expenditures in Pharmaceutical Companies
  • 5.2 Market Restraints
    • 5.2.1 High Cost Involved in Development of Drug Delivery Systems
  • 5.3 Market Opportunities
    • 5.3.1 Development of New Lipid Composition for Stability and Optimization of Drugs
  • 5.4 Future Trends
    • 5.4.1 Increasing Popularity of Liposomes in Drug Delivery
  • 5.5 Impact Analysis

6. Liposome Drug Delivery Market - North America Analysis

  • 6.1 North America Liposome Drug Delivery Market Revenue Forecasts and Analysis

7. North America Liposome Drug Delivery Market Analysis and Forecasts To 2027 - By Product Overview

  • 7.1 North America Liposome Drug Delivery Market, By Product Type 2019 & 2027 (%)
    • 7.1.1 North America Liposome Drug Delivery Market Revenue and Forecasts to 2027, By Product Type (US$ Mn)
  • 7.2 Liposomal Doxurubicin
    • 7.2.1 Overview
    • 7.2.2 North America Liposome Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
  • 7.3 Liposomal Paclitaxel
    • 7.3.1 North America Liposomal Paclitaxel Market Revenue and Forecasts to 2027 (US$ Mn)
  • 7.4 Liposomal Amphotericin B
    • 7.4.1 overview
    • 7.4.2 North America Liposomal Amphotericin B forecast and market revenue
  • 7.5 Others
    • 7.5.1 overview
    • 7.5.2 North America Other Liposome Drug Delivery Market overview and forecast to 2027

8. North America Liposome Drug Delivery Market - By Technology

  • 8.1 Overview
  • 8.2 North America Liposome Drug Delivery Market, by Technology, 2019 and 2027 (%)
  • 8.3 Stealth Liposome Technology
    • 8.3.1 Overview
    • 8.3.2 North America Stealth Liposome Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.4 Non-PEGylated Liposome Technology
    • 8.4.1 Overview
    • 8.4.2 North America Non-PEGylated Liposome Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.5 DepoFoam Liposome Technology
    • 8.5.1 Overview
    • 8.5.2 North America DepoFoam Liposome Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.6 Lysolipid Thermally Sensitive Liposome (LTSL) Technology
    • 8.6.1 Overview
    • 8.6.2 North America Lysolipid Thermally Sensitive Liposome (LTSL) Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)

9. North America Liposome Drug Delivery Market - By Application

  • 9.1 Overview
  • 9.2 North America Liposome Drug Delivery Market, by Application, 2019 and 2027 (%)
  • 9.3 Fungal Diseases
    • 9.3.1 Overview
    • 9.3.2 Fungal Diseases: North America Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.4 Cancer Therapy
    • 9.4.1 Overview
    • 9.4.2 Cancer Therapy: North America Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.5 Pain Management
    • 9.5.1 Overview
    • 9.5.2 Pain Management: North America Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.6 Viral Vaccine
    • 9.6.1 Overview
    • 9.6.2 Viral Vaccine: North America Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.7 Photodynamic Therapy
    • 9.7.1 Overview
    • 9.7.2 Photodynamic Therapy: North America Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)

10. North America Liposome Drug Delivery Market - Geographic Analysis

  • 10.1 North America: Liposome Drug Delivery Market
    • 10.1.1 Overview
    • 10.1.2 North America: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
    • 10.1.3 North America Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
    • 10.1.4 North America Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
    • 10.1.5 North America Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 10.1.6 North America: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)
    • 10.1.7 US: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.1 US: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.2 US Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.3 US Skin aesthetic devices market, by Technology - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.4 US Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 10.1.8 Canada: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.1 Canada: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.2 Canada Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.3 Canada Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.4 Canada Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 10.1.9 Mexico: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.1 Mexico: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.2 Mexico Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.3 Mexico Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.4 Mexico Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)

11. Impact Of COVID-19 Pandemic On North America Liposome Drug Delivery Market

  • 11.1 North America: Impact Assessment of COVID-19 Pandemic

12. Company Profiles

  • 12.1 Takeda Pharmaceutical Company Limited
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.3 Novartis AG
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.5 Luye Pharma Group
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Johnson & Johnson Services, Inc.
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Ipsen Pharma
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments

13. Appendix

  • 13.1 About the Insight Partners
  • 13.2 Word Index

List Of Tables

  • Table 1. R&D Investments by major pharmaceutical companies
  • Table 2. North America Liposome Drug Delivery Market Revenue and Forecasts To 2027, By Product Type (US$ Mn)
  • Table 3. North America Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 4. North America Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 5. North America Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 6. US Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 7. US Skin aesthetic devices market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 8. US Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 9. Canada Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 10. Canada Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 11. Canada Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 12. Mexico Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 13. Mexico Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 14. Mexico Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 15. List of Abbreviation

List Of Figures

  • Figure 1. Liposome Drug Delivery Market Segmentation
  • Figure 2. North America Liposome Drug Delivery Segmentation : By Region
  • Figure 3. North America Liposome Drug Delivery Market Overview;
  • Figure 4. Others Segment Held Largest Share of Product Type in Liposome Drug Delivery Market
  • Figure 5. US is Expected to Show Remarkable Growth During the Forecast Period.
  • Figure 6. Liposome Drug Delivery Market - North America PEST Analysis
  • Figure 7. North America Liposome Drug Delivery Market Impact Analysis of Driver and Restraints
  • Figure 8. North America Liposome Drug Delivery Market - Revenue Forecasts and Analysis - 2019- 2027
  • Figure 9. North America Liposome Drug Deliverys Market, By Product Type 2019 & 2027 (%)
  • Figure 10. North America Liposomal Doxurubicin Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 11. North America Liposomal Paclitaxel Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 12. North America Liposomal Amphotericin B market revenue and forecast to 2027
  • Figure 13. North America Other Liposome Drug Delivery Market overview and forecast to 2027
  • Figure 14. North America Liposome Drug Delivery Market, by Technology, 2019 and 2027 (%)
  • Figure 15. North America Stealth Liposome Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 16. North America Non-PEGylated Liposome Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 17. North America DepoFoam Liposome Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 18. North America Lysolipid Thermally Sensitive Liposome (LTSL) Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 19. North America Liposome Drug Delivery Market, by Application, 2019 and 2027 (%)
  • Figure 20. Fungal Diseases: North America Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 21. Cancer Therapy: North America Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 22. Pain Management: North America Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 23. Viral Vaccine: North America Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 24. Photodynamic Therapy: North America Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 25. North America: Liposome Drug Delivery Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 26. North America Liposome Drug Delivery Market Revenue and Forecast to 2027 (USD Million)
  • Figure 27. North America: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)
  • Figure 28. US: Liposome Drug Delivery market - Revenue and Forecast to 2027 (USD Million)
  • Figure 29. Canada: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 30. Mexico: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 31. Impact of COVID-19 Pandemic In North American Country Markets
Back to Top